0114 232 9292 connect@medilink.co.uk


Ceftolozane/tazobactam 30/10 now available from Medilink member Mast!

Medilink member Mast have recently announced the launch of a new addition to the Mastdiscs® stock cartridge range – Ceftolozane/tazobatam 30/10 (C/T40C), is now available! Merck (MSD) has launched the new intravenous antibiotic Zerbaxa® (Ceftolozane/tazobactam) in the UK for the treatment of complicated intra-abdominal infections, acute pyelonephritis and complicated urinary tract infections in nosocominal environments.…
Read more

Huddersfield company travels to Texas to promote UK healthcare innovation

A Huddersfield scalp cooling manufacturer is one of 9 UK companies representing the country’s health and life science industry in Texas next week. Paxman, who manufacture and supply an innovative medical device for the prevention of chemotherapy-induced alopecia (CIA), will form part of a delegation consisting of innovative medical technology companies. It is the first…
Read more

Free for Medilink members – PR & Social Media briefing with added networking

Medilink is delighted to announce a fantastic opportunity to learn for free how PR and Social Media output can have a positive impact for healthcare technology organisations. Delivered by sector specialists, the event will offer an overview of the most effective uses of PR and social media tools and platforms, the positive impact of proactive…
Read more

Medilink member Mast exhibiting at BSMT Spring Meeting 2016

Mast is delighted to be exhibiting once again at the BSMT Spring Meeting, located at Public Health England, Colindale, Friday 20th May 2016. The one day symposium is titled ‘Assessing the Impact of New Technology in Diagnostics on Global Epidemiology: How Laboratories make a Difference’. The meeting aims to discuss how laboratories identify and quantify…
Read more